Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of heart rate and autonomic nervous system modulation on inflammation and peripheral vascular function in type 2 diabetes
2008-003773-41Phase 4Completed
- Sponsor
- Policlinico Gemelli
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ivabradine and atenolol in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Policlinico Gemelli. Started Aug 2008; status: completed.
02
Drugs
ivabradineatenolol
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-003773-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003773-41.